抗原
免疫系统
卵清蛋白
接种疫苗
免疫学
癌症疫苗
癌症免疫疗法
病毒载体
交叉展示
CTL公司*
癌症研究
免疫疗法
免疫
细胞免疫
生物
免疫
表位
模块化设计
细胞毒性T细胞
抗体
医学
类病毒颗粒
主要组织相容性复合体
脾脏
化学
肽
获得性免疫系统
免疫原性
抗原处理
佐剂
肿瘤抗原
细胞穿透肽
移植排斥反应
癌细胞
作者
Jiabao Han,Elena A. Kashentseva,Igor P. Dmitriev,Zhi Hong Lu,Simon Peter Goedegebuure,Lijin Li,William E. Gillanders,David T. Curiel
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-11-03
标识
DOI:10.1021/acsnano.6c03263
摘要
Abstract Adenoviral vectors have been widely validated as effective vaccine platforms for both infectious diseases and cancer due to their strong immunostimulatory properties. However, their application to personalized cancer vaccines and other time-sensitive antigens is limited by the prolonged production time required for conventional vector generation. Here, we developed an adenovirus-derived virus-like particle (Ad5VLP) platform that enables modular incorporation of antigen cargo without reconstruction of a complete antigen-encoding adenoviral genome. Ad5VLPs successfully packaged and delivered foreign mRNA, although mRNA-derived antigen expression remained insufficient to induce robust antigen-specific immunity in vivo. In contrast, direct encapsulation of protein or peptide antigens substantially improved intracellular antigen delivery and major histocompatibility complex (MHC) class I antigen presentation. Following subcutaneous prime-boost immunization in mice, antigen-loaded Ad5VLPs induced robust antigen-specific interferon-γ (IFN-γ) responses, with functional activity preferentially enriched within CD44hi CD8+ T cells and accompanied by effector-associated CD8+ T-cell differentiation. Importantly, robust cellular immune responses were also observed using an E0771 tumor neoantigen, demonstrating that the platform extends beyond the model ovalbumin (OVA) antigen. Protein-loaded Ad5VLPs also elicited antigen-specific and antivector humoral responses. Vaccination was well tolerated over the 14 day study period, with no substantial changes in body weight, clinical observations, serum markers of hepatic or renal injury and systemic inflammation, or broad splenic inflammatory transcriptional signatures. Together, these findings demonstrate that Ad5VLPs enable modular delivery of protein and peptide antigens and induce robust cellular immune responses, supporting further investigation for personalized cancer vaccination and other time-sensitive vaccine applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI